154 related articles for article (PubMed ID: 460538)
1. Effects of bromocriptine on plasma catecholamines in normal men.
Van Loon GR; Sole MJ; Bain J; Ruse JL
Neuroendocrinology; 1979; 28(6):425-34. PubMed ID: 460538
[TBL] [Abstract][Full Text] [Related]
2. Plasma ACTH, cortisol, LH, FSH, testosterone, and dihydrotestosterone responses to bromocriptine in normal men.
Van Loon GR; Bain J; Ruse JL
Arch Androl; 1980 Feb; 4(1):1-7. PubMed ID: 6243912
[TBL] [Abstract][Full Text] [Related]
3. Effect of bromocriptine on plasma catecholamines in normal subjects and prolactin-secreting tumor patients.
Mancini AM; Barontini M; Armando I; Levin G; Kleiman A; Razumny J; Molocznik I
J Endocrinol Invest; 1986 Jun; 9(3):223-6. PubMed ID: 3760461
[TBL] [Abstract][Full Text] [Related]
4. The effect of bromocriptine on plasma catecholamine concentrations in normal volunteers.
Steardo L; Di Stasio E; Bonuso S; Maj M
Eur J Clin Pharmacol; 1986; 29(6):713-5. PubMed ID: 3709615
[TBL] [Abstract][Full Text] [Related]
5. [Effects of bromocriptine and dopamine on pituitary hormone secretion in women].
Masaoka K; Hosoya N; Mori T; Watanabe H; Ohkura T; Kumasaka T
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Dec; 34(12):2155-62. PubMed ID: 6818310
[TBL] [Abstract][Full Text] [Related]
6. Effects of different dopaminergic antagonists on bromocriptine-induced inhibition of norepinephrine release.
Mannelli M; Delitala G; De Feo ML; Maggi M; Cuomo S; Piazzini M; Guazzelli R; Serio M
J Clin Endocrinol Metab; 1984 Jul; 59(1):74-8. PubMed ID: 6725527
[TBL] [Abstract][Full Text] [Related]
7. Abnormal plasma catecholamine responses in acromegalics.
Van Loon GR
J Clin Endocrinol Metab; 1979 May; 48(5):784-9. PubMed ID: 372207
[TBL] [Abstract][Full Text] [Related]
8. Catecholamine turnover rates in discrete hypothalamic areas and associated changes in median eminence luteinizing hormone-releasing hormone and serum gonadotropins on proestrus and diestrous day 1.
Rance N; Wise PM; Selmanoff MK; Barraclough CA
Endocrinology; 1981 May; 108(5):1795-802. PubMed ID: 6783392
[TBL] [Abstract][Full Text] [Related]
9. Enhanced depressor effect of bromocriptine in the DOCA/NaCl hypertensive rat.
Nagahama S; Chen YF; Oparil S
Am J Physiol; 1985 Jul; 249(1 Pt 2):H64-70. PubMed ID: 2861750
[TBL] [Abstract][Full Text] [Related]
10. Bromocriptine decreases blood pressure of spontaneously hypertensive rats without affecting the adrenomedullary synthesis of catecholamines.
Racz K; Kuchel O; Buu NT
J Cardiovasc Pharmacol; 1986; 8(4):676-80. PubMed ID: 2427803
[TBL] [Abstract][Full Text] [Related]
11. Plasma catecholamines during endotoxin infusion in conscious unrestrained rats: effects of adrenal demedullation and/or guanethidine treatment.
McKechnie K; Dean HG; Furman BL; Parratt JR
Circ Shock; 1985; 17(1):85-94. PubMed ID: 3902274
[TBL] [Abstract][Full Text] [Related]
12. Suppression of basal and stimulated noradrenergic activities by the dopamine agonist bromocriptine in man.
Carey RM; Van Loon GR; Baines AD; Kaiser DL
J Clin Endocrinol Metab; 1983 Mar; 56(3):595-602. PubMed ID: 6822657
[TBL] [Abstract][Full Text] [Related]
13. The dopamine agonist bromocriptine induces hypotension by venous and arteriolar dilation.
Johns DW; Ayers CR; Carey RM
J Cardiovasc Pharmacol; 1984; 6(4):582-7. PubMed ID: 6206310
[TBL] [Abstract][Full Text] [Related]
14. Bromocriptine-induced orthostatic hypotension.
Van Loon GR
Clin Invest Med; 1979; 2(4):131-4. PubMed ID: 549762
[No Abstract] [Full Text] [Related]
15. Plasma catecholamine responses to change of posture in alcoholics during withdrawal and after continued abstinence from alcohol.
Eisenhofer G; Whiteside EA; Johnson RH
Clin Sci (Lond); 1985 Jan; 68(1):71-8. PubMed ID: 3964731
[TBL] [Abstract][Full Text] [Related]
16. Bromocriptine reduces plasma noradrenaline and 3,4-dihydroxyphenylacetic acid in normal and hypotensive subjects.
Mercuro G; Rossetti ZL; Tocco L; Rivano CA; Cherchi A; Gessa GL
Eur J Clin Pharmacol; 1985; 27(6):671-5. PubMed ID: 3987772
[TBL] [Abstract][Full Text] [Related]
17. Plasma catecholamine and glucose concentrations during hemorrhagic hypotension in anesthetized dogs.
Briand R; Yamaguchi N; Gagne J
Am J Physiol; 1989 Aug; 257(2 Pt 2):R317-25. PubMed ID: 2764156
[TBL] [Abstract][Full Text] [Related]
18. Prolactin-releasing action of LRF: a central catecholamine mediated event?
Zhang YW; Yen SS
Life Sci; 1984 Feb; 34(7):653-7. PubMed ID: 6366415
[TBL] [Abstract][Full Text] [Related]
19. Failure of bromocriptine to lower plasma catecholamines in normal men and women.
Bybee DE; Wiesen M; Aronin N; Krieger DT; Frohman LA; Kopin IJ
J Clin Endocrinol Metab; 1982 Mar; 54(3):648-50. PubMed ID: 6276434
[TBL] [Abstract][Full Text] [Related]
20. Effect of bromocriptine on insulin, growth hormone and prolactin responses to arginine in obesity.
Maccario M; Grottoli S; Procopio M; Oleandri SE; Barberis A; Ciccarelli E; Camanni F; Ghigo E
J Endocrinol Invest; 1996 Apr; 19(4):219-23. PubMed ID: 8862501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
